Context Therapeutics Inc is trading 7.9% up at $1.64 following the June 9 regular session close, despite a lack of company-specific news or announcements to explain the move.
- The price increase may reflect thin after-hours liquidity or shifts in broad risk sentiment rather than fundamental developments.
- No earnings releases, regulatory filings, or major late-breaking updates were identified in available sources to account for the volatility.